Effect of putative efflux pump inhibitors and inducers on the antimicrobial susceptibility of Campylobacter jejuni and Campylobacter coli

References

1. Aumercier M., Murray D. M., Rosner J. L. 1990; Potentiation of susceptibility to aminoglycosides by salicylate in Escherichia coli . Antimicrob Agents Chemother 34:786–791 [CrossRef]
   [Google Scholar]
2. Bohnert J. A., Kern W. V. 2005; Selected arylpiperazines are capable of reversing multidrug resistance in Escherichia coli overexpressing RND efflux pumps. Antimicrob Agents Chemother 49:849–852 [CrossRef]
   [Google Scholar]
3. Bolla J. M., Loret E., Zalewski M., Pagés J. M. 1995; Conformational analysis of the Campylobacter jejuni porin. J Bacteriol 177:4266–4271
   [Google Scholar]
4. Cagliero C., Mouline C., Payot S., Cloeckaert A. 2005; Involvement of the CmeABC efflux pump in the macrolide resistance of Campylobacter coli . J Antimicrob Chemother 56:948–950 [CrossRef]
   [Google Scholar]
5. CLSI 2006 Performance Standards for Antimicrobial Susceptibility Testing Supplement M100S16 Wayne, PA: Clinical and Laboratory Standards Institute;
   [Google Scholar]
6. Corcoran D., Quinn T., Cotter L., O'Halloran F., Fanning S. 2005; Characterization of a cmeABC operon in a quinolone-resistant Campylobacter coli isolate of Irish origin. Microb Drug Resist 11:303–308 [CrossRef]
   [Google Scholar]
7. Friedman C. R., Neimann J., Wegener H. C., Tauxe R. V. 2000; Epidemiology of Campylobacter jejuni infections in the United States and other industrialized nations. In Campylobacter , 2nd edn. pp 121–138 Edited by Nachamkin I., Blaser M. J. Washington, DC: American Society for Microbiology;
   [Google Scholar]
8. Gibreel A., Wetsch N. M., Taylor D. E. 2007; Contribution of the CmeABC efflux pump to macrolide and tetracycline resistance in Campylobacter jejuni . Antimicrob Agents Chemother 51:3212–3216 [CrossRef]
   [Google Scholar]
9. Hänninen M. L., Hannula M. 2007; Spontaneous mutation frequency and emergence of ciprofloxacin resistance in Campylobacter jejuni and Campylobacter coli . J Antimicrob Chemother 60:1251–1257 [CrossRef]
   [Google Scholar]
10. Lin J., Michel L. O., Zhang Q. 2002; CmeABC functions as a multidrug efflux system in Campylobacter jejuni . Antimicrob Agents Chemother 46:2124–2131 [CrossRef]
    [Google Scholar]
11. Lin J., Cagliero C., Guo B., Barton Y. W., Maurel M. C., Payot S., Zhang Q. 2005; Bile salts modulate expression of the CmeABC multidrug efflux pump in Campylobacter jejuni . J Bacteriol 187:7417–7424 [CrossRef]
    [Google Scholar]
12. Lomovskaya O., Warren M. S., Lee A., Galazzo J., Fronko R., Lee M., Blais J., Cho D., Chamberland S. other authors 2001; Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa : novel agents for combination therapy. Antimicrob Agents Chemother 45:105–116 [CrossRef]
    [Google Scholar]
13. Pannek S., Higgins P. G., Steinke P., Jonas D., Akova M., Bohnert J. A., Seifert H., Kern W. V. 2006; Multidrug efflux inhibition in Acinetobacter baumannii : comparison between 1-(1-naphthylmethyl)-piperazine and phenyl-arginine-beta-naphthylamide. J Antimicrob Chemother 57:970–974 [CrossRef]
    [Google Scholar]
14. Payot S., Avrain L., Magras C., Praud K., Cloeckaert A., Chaslus-Dancla E. 2004; Relative contribution of target gene mutation and efflux to fluoroquinolone and erythromycin resistance, in French poultry and pig isolates of Campylobacter coli . Int J Antimicrob Agents 23:468–472 [CrossRef]
    [Google Scholar]
15. Price C. T., Lee I. R., Gustafson J. E. 2000; The effects of salicylate on bacteria. Int J Biochem Cell Biol 32:1029–1043 [CrossRef]
    [Google Scholar]
16. Randall L. P., Ridley A. M., Cooles S. W., Sharma M., Sayers A. R., Pumbwe L., Newell D. G., Piddock L. J., Woodward M. J. 2003; Prevalence of multiple antibiotic resistance in 443 Campylobacter spp. isolated from humans and animals. J Antimicrob Chemother 52:507–510 [CrossRef]
    [Google Scholar]
17. Ruiz J., Marco F., Oliveira I., Vila J., Gascon J. 2007; Trends in antimicrobial resistance in Campylobacter spp. causing traveler's diarrhea. APMIS 115:218–224 [CrossRef]
    [Google Scholar]
18. Schumacher A., Steinke P., Bohnert J. A., Akova M., Jonas D., Kern W. V. 2006; Effect of 1-(1-naphthylmethyl)-piperazine, a novel putative efflux pump inhibitor, on antimicrobial drug susceptibility in clinical isolates of Enterobacteriaceae other than Escherichia coli . J Antimicrob Chemother 57:344–348 [CrossRef]
    [Google Scholar]